Veterinary Injectable Devices Market Size & Share 2025 - 2034

Veterinary Injectable Devices Market Size

The global veterinary injectable devices market was valued at USD 931 million in 2024. The market is expected to grow from USD 967.8 million in 2025 to USD 1.5 billion in 2034, at a CAGR of 4.9% during the forecast period, according to the latest report published by Global Market Insights Inc.

This growth is attributed to the rising global pet ownership, increasing animal healthcare spending, growing expansion of livestock farming and mass vaccination programs. In addition, the growing burden of zoonotic and infectious disease, with rising advancement in injectable technologies, further contributes to market growth.
 

The veterinary injectable devices market refers to the segment of the animal healthcare industry focused on devices used to administer injectable drugs, vaccines, and biologics to animals. These devices are essential for delivering precise dosages and ensuring effective treatment across various species, including livestock, poultry, and companion animals. Major players in the industry are Zoetis, Henke-Sass, Wolf, Merck & Co., Neogen Corporation and NuGen Medical Devices. These players dominated the market by adopting various strategies such as product expansion and establishing global distribution networks.
 

Veterinary injectable devices witness steady growth, growing from USD 832.9 million in 2021 to USD 896 million in 2023. The growth of the market is driven by increasing number of companion animals such as dogs, cats, horses and others. Thus, the rapid increase in the number of companion and livestock animals raises the demand for vaccines, antibiotics, veterinary pain management and chronic disease treatment that completely rely on injectables. Further, the growing concerns over animal health, higher biosecurity standards, and increasing shift towards preventive healthcare especially vaccines have fueled the market growth. Additionally, the increasing adoption of safety syringes, retractable needles, and needle-free jet injectors is increasing to minimize needlestick injuries in animals, improve compliance and enable faster herd vaccination, these factors collectively reshaping the future landscape of the veterinary injectable devices market.
 

Moreover, the national government and veterinary associations mandate vaccination programs for rabies, foot-and-mouth disease, brucellosis and various others. Thus, the increasing initiatives by government and private organization with regulatory approval for safer injection devices increases the adoption of veterinary injectable devices, thereby contributing to the market growth. For instance, India launched a USD 120 million national FMD vaccination drive for cattle. Animal Husbandry department officials said that all necessary logistics were in place to ensure cent per cent coverage of the targeted cattle population of 4.54 lakh in the district.
 

The vaccination drive will be held under the National Animal Disease Prevention Programme. Similarly, in September 2023, MSD Animal Health, a division of Merck & Co. announced it has donated more than 5 million NOBIVAC rabies vaccines through the Company’s Afya Program, since it was founded. In partnership with Mission Rabies and Rabies Free Africa, MSD Animal Health is celebrating this milestone as well as a more than 25-year commitment by reinforcing its commitment to eliminate rabies.
 

The market is further strengthened by prompting investment in animal healthcare infrastructure in developing economies, particularly in the Asia-Pacific and Latin America regions. The veterinary injectable devices is poised for significant growth owing to increasing research and development initiatives aimed at developing novel therapeutics with improved efficacy and lesser side effects. These factors are expected to increase the adoption of veterinary injectable devices for companion and livestock animals in the upcoming years. Thus, the growing incidence of livestock disease, coupled with advancement in animal healthcare, fostering growth within the veterinary injectable devices.
 

Veterinary Injectable Devices Market Trends

• The global veterinary injectable devices industry experiencing dynamic transformation driven by the increasing pet ownership and intensifying livestock production expand baseline demand for vaccines, biologics and routine injectables.
   
• Moreover, increasing shift towards premium combination products as companion animal owners spend more and pet insurance rises, further drives the growth of the market. For instance, in 2024, U.S. pet expenditure surpassed USD 151.9 billion, with veterinary services making up ~USD 40 billion as per the report published by American Pet Products Association (APPA). Thus, the willingness of pet owners to pay for high-quality care fuels innovation in ergonomic syringes, autoinjectors, and safety-engineered needles, ensuring comfort, compliance and better treatment outcomes.
   
• Furthermore, growing public-health and campaign driven demand due to large vaccination campaigns for rabies, FMD, avian influenza and others creates periodic large procurements that materially affects volume and planning for manufacturers and distributors.
   
• Additionally, companion animals medicine is evolving towards personalized, precision-based care, mirroring human healthcare trends. Treatments for chronic conditions like diabetes, arthritis, and cancer in dogs and cats require highly controlled drug administration. This has created demand for prefilled syringes, autoinjectors, and smart injectors designed for home or veterinary clinic use. The trend aligns with the growth of monoclonal antibodies, biologics and specialty drugs in veterinary medicine where dosing accuracy and minimal pain are crucial.
   
• Emerging markets particularly in Asia Pacific, Latin America and Sub-Saharan Africa are increasingly contributing to shaping the future of the veterinary injectable devices. These regions are witnessing rapid population growth, increasing demand for injectable devices, expanding companion and livestock population, and improving veterinary infrastructure. Moreover, supportive health policy, awareness campaigns, and entry by international manufacturers through partnership or local manufacturing units accelerate the market growth.
   
• Regulatory bodies in North America and Europe are enforcing stricter controls on sharps disposal and biohazard management in veterinary settings. This is pushing clinics firms and manufacturers to adopt safety-engineered needles, retractable syringes, and needle-free devices. By minimising risk of needle stick injuries, cross contamination and environmental hazards, these devices align with evolving guidelines. For example, the EU requires standardized disposal protocols for veterinary sharps, while the U.S. OSHA promotes injury-prevention mechanisms.
   
• Overall, the market is evolving rapidly with the increasing adoption of automated production lines, robotics, and high speed-injection design to scale veterinary injectable device production. Automation reduces costs, ensure consistent quality and improves efficiency enabling companies to meet the growing global demand for syringes and needles.
   

Veterinary Injectable Devices Market Analysis

Based on product, the global veterinary injectable devices market is divided into syringes, needles, remote injectable devices, needle-free injector systems, auto-injectors and other injectable devices. The syringes segment accounted for 29.3% of the market in 2024 due to high demand for routine vaccination and therapeutics, ease of use, affordability and availability and growing shift from reusable to disposable syringes.
 

The segment is expected to exceed USD 437.5 million by 2034, growing at a CAGR of 4.9% during the forecast period. On the other hand, needle-free injector systems segment is expected to grow with the fastest CAGR of 5.3%. The growth of this segment can be attributed to growing awareness among pet owners and veterinarians to eliminate risk of needle-stick injuries.
 

• Veterinary syringes are indispensable for routine procedures such as vaccination, antibiotic administration, and deworming in both livestock and companion animals. Rising pet ownership and global initiatives for livestock disease control such as FAO supported vaccination drives against foot and mouth disease and rabies have significantly boosted syringe demand.
   
• Moreover, syringes are the most accessible, low-cost and versatile injectable devices on the market. Farmers, veterinary technicians, and pet owners are accustomed to their use, reducing training barrier. In addition, their ability to deliver precise volume of medication at low cost ensures continued dominance. Thus, this affordability factor makes syringes especially attractive in emerging markets, where cost sensitivity remains a key decision driver, thereby contributing market growth.
   
• Veterinary syringes are evolving with ergonomic designs, lightweight materials, multi dose auto-syringes for farms and customizable sizes suited for different species. For example, multi-dose syringes allow farmers to vaccinate large herds efficiently while smaller precision syringes cater to dedicate pets.
   
• Innovations like graduated markings for accuracy, smoother plungers, and biocompatible plastics improve both usability and safety. This product improvement enhance user experience, increase efficiency in mass operation and makes syringes suitable across varied veterinary contexts, thereby driving adoption.
   
• On the other hand, needle-free injector systems segment is expected to grow with the fastest CAGR during the analysis period. The growth of needle-free injector system is driven by the rising emphasis on animal welfare standards across both livestock and companion animal care.
   
• Traditional needles often cause pain, stress and risk of injury during handling especially in large herds or sensitive pets. Needle free injectors minimise these issues by delivering vaccines and drugs without penetration reducing handling stress and improving compliance with welfare regulations.
   

Based on the material, the veterinary injectable devices market is segmented into plastic, metal, glass, and other materials. The plastic material segment dominated the market in 2024 with a revenue of USD 459 million.
 

• Plastic materials are more affordable to produce, and scale compared to glass. High-volume, injection molding allows for low-cost, disposable syringes and needles critical for mass livestock vaccination campaigns. Moreover, the ability to mass-produce lightweight, durable devices makes plastics the preferred choice for both developed and emerging markets, ensuring wide accessibility, thereby contributing to market growth.
   
• Moreover, plastic material enable the production of single-use syringes and needles, thereby reducing the risk of cross contamination and infection spread among animals. In addition, unlike reusable metal devices, plastic injectables are designed for disposable, sterile use aligning with modern veterinary hygiene practices, these factors collectively drives the adoption of plastic injectable devices for veterinary use, spurring market growth.
   
• On the other hand, the market for glass material is expected to expand more rapidly owing to its properties of resistant to chemical interactions with drugs, vaccines, and biologics. Moreover, the growing shift toward ready-to-use injectables is major growth driver for glass, pre-filled syringes, which offer precision dosing, sterility and convenience are increasingly being adopted in veterinary practice.
   
• Glass syringe is expected to grow significantly due to their proven ability to maintain drug stability, barrier properties, and sterility.
   

Based on clinical application, the veterinary injectable devices market is classified into vaccination and preventive care, anti-infectives, anesthesia and analgesia, fertility and reproduction and other clinical applications. The vaccination and preventive care segment dominated the market in 2024 and is growing with a CAGR of 5.1% during the forecast period.
 

• The segment is gaining significant traction due to the high prevalence of zoonotic disease such as rabies, avian influenza, and brucellosis that remain major public health concerns. Vaccination of companion animals and livestock animals is the most effective preventive measure, driving sustained demand for injectable devices. For instance, rabies kills nearly 59,000 people annually worldwide as per the World Health Organization report. Thus, the large scale immunization campaigns, against zoonotic pathogens ensure consistent use of veterinary syringes, needles and needle-free devices, thereby contributing to market growth.
   
• Further, the introduction of needle-free injectors, multi-dose auto-syringes, and prefilled syringes has enhanced safety, efficiency, and compliance in vaccination. These technologies allow faster vaccination during mass campaigns, reduce needle-stick injuries, and minimize cross-contamination. Needle-free devices, in particular are gaining adoption for swine and poultry vaccines, where biosecurity are critical.
   
• The second-largest segment, anti-infectives, held a market share of 20.3% in 2024. The market growth for anti-infectives is driven by high prevalence of infectious diseases in animals creating demand for injectable antibiotics, antifungals, and antivirals. For instance, the World Health Organization for Animal Health (WOAH) estimates infectious diseases cause 20% of global livestock production losses annually, making anti-infective injectables critical for farm productivity and animal welfare.
   

Based on usage, the veterinary injectable devices market is bifurcated into disposable devices and reusable devices. The disposable devices segment was anticipated to be worth of USD 524.1 million in 2024 and is expected to grow at 4.6% CAGR during the forecast period.
 

• Disposable devices significantly reduce the risk of cross-contamination, disease transmission, and infection compared to reusable syringes. In large livestock operations, where multiple animals are injected in quick succession, single-use devices ensure sterility and compliance with farm biosecurity protocols. This strong emphasis on infection prevention is a major driver for adoption across both companion animal clinics and commercial livestock production.
   
• In addition, stricter regulations regarding needle-stick injuries, sharps disposal, and contamination risks are driving demand for disposable veterinary injectables.
   
• The increasing availability of medical-grade polymers, biocompatible plastics and eco-friendly disposable materials has lowered production costs and improved the safety of single-use injectables. Manufacturing innovations such as automated molding and large-scale production lines makes disposable affordable and accessible globally.
   
• Lastly, the rise of pet humanization has increased demand for advanced, hygienic, and safety veterinary procedures. Pet owners prefer disposable injectables as they minimize risks of infections and ensure a more comfortable treatment experience for their animals. The growing prevalence of chronic conditions in pets, such as diabetes and arthritis, requiring repeated injections also fuels adoption of prefilled, disposable syringes and autoinjectors for ease of use and accuracy.
   

Based on animal type, the veterinary injectable devices market is bifurcated into companion animals, livestock animals and other animals. The companion animals’ segment was anticipated to be worth of USD 469 million in 2024.
 

• The global increase in pet ownership, particularly in urban middle-class households, is fueling demand for advanced veterinary care. For instance, approximately 66% of U.S. households own a pet, which translates to roughly 86.9 million households according to the latest estimates from the American Pet Products Association (APPA). The APPA also reports that 94 million U.S. households own a pet, representing 71% of the total.
   
• This trend drives the demand for safe, precise and user-friendly injectable devices, such as prefilled syringes and autoinjectors, that ensure comfort and reduce stress.
   
• In addition, companion animals’ owners and veterinarians are increasingly focused on minimizing pain and stress during injections. Devices with ergonomic grips, ultra-thin needles, and needle-free injectors are gaining traction in clinics and at-home care, thereby driving the market growth.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, veterinary injectable devices market is classified into veterinary hospitals, veterinary clinics, academic and research institutes, and other end users. The veterinary hospitals segment dominated the market in 2024 and is expected to reach 412.7 million within the forecast period.
 

• Veterinary hospitals are the primary centers for complex and specialized treatments, such as surgeries, oncology, chronic disease management and vaccinations. Hospitals are increasingly equipped with advanced injection technologies to improve accuracy, safety and animal comfort, thus the growing preference for professional hospital based treatments, strongly boost injectable devices usage in this segment.
   
• The veterinary hospital sector is consolidating into corporate chains and specialty centers such as Mars Veterinary Health and IVC Evidensia. These networks invest heavily in modern infrastructure, standardized equipment and training, ensuring widespread adoption of advanced injection across their hospital chains thereby contributing market growth.
   
• Lastly, hospitals handle the largest share of vaccinations, deworming, emergency treatments and routine preventive care, all of which require injectables. Therefore, the high volume and variety of injectable procedure make hospitals the most critical end-user, ensuring steady demand for devices across both companion and livestock animals.
   

North America Veterinary Injectable Devices Market
 

The North America market dominated the global veterinary injectable devices market with a market share of 41.1% in 2024.
 

• The region has one of the highest pet ownership rates globally, with nearly 66% of U.S. households owning pets. The growing awareness among pet owners regarding availability of advanced veterinary care leads to driving adoption of safe, precise, and ergonomic injectable devise, that further contributes to market growth.
   
• Moreover, North America led in the development of veterinary biologics, vaccines and monoclonal antibodies. Products such as Zoetis, Librela and Solenisa rely on precise injectable delivery systems. This led to growing demand for autoinjectors, prefilled syringes and safety syringes, that drives the growth of the market.
   
• In addition, the U.S. FDA Center for Veterinary Medicine (CVM) and USDA’s Center for Veterinary Biologics regulate veterinary devices and biologics with strict quality and safety requirements. Clear regulatory requirements enable faster commercialization of next-generation technologies such as jet injectors and connected devices, making North America an attractive hub for innovation and early adoption of veterinary injectable devices.
   

The U.S. veterinary injectable devices was valued at USD 320.2 million and USD 330.4 million in 2021 and 2022, respectively. The market size reached USD 353.3 million in 2024, growing from USD 341.5 million in 2023.
 

• U.S. livestock industry including cattle, swine, poultry is highly intensive requiring mass vaccination and therapeutic programmes to protect against outbreaks like avian influenza, bovine respiratory disease and swine fever. Injectable devices such as multi dose automatic syringes and needle free systems are essential to manage large herds efficiently. In addition, the U.S. government through bodies like USDA-APHIS provides strict disease surveillance, funding and support for vaccination during outbreaks.
   
• The government initiatives such as National Poultry Improvement Plan (NPIP) promote biosecurity and immunization, encouraging farms to adopt standardized vaccination protocols, that drives the growth of the market.
   

Europe Veterinary Injectable Devices Market
 

Europe veterinary injectable devices accounted for USD 281.4 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Europe plays a critical role in the global veterinary injectable devices, supported by its advanced healthcare infrastructure, strict veterinary pharmaceutical regulations, and a strong emphasis on animal welfare.
   
• Moreover, Europe is a leader in precision livestock farming, where technology plays a major role in herd management. Smart syringes and connected injection systems that integrate with RFID tagging and herd health software are increasingly used for monitoring treatment compliance and vaccination records.
   
• In addition, the increasing focus on efficiency, traceability, and animal welfare encourages rapid uptake of smart, connected and automated injectable devices across the European veterinary sector.
   
• Moreover, Europe is at the forefront of veterinary biotech innovation with key players in the market developing advanced poultry vaccine such as vector-based and recombinant poultry vaccines, that raises the demand for advanced veterinary injectable devices, thereby driving the market growth.
   

Germany dominates the European veterinary injectable devices market, showcasing strong growth potential.
 

• Germany’s animal healthcare sector is seeing active innovation such as Boehringer’s launches of vaccines for porcine parvovirus and Marek’s disease indication strong uptake of injectable based solutions.
   
• Germany’s robust livestock sector operates under rigorous animal welfare and disease prevention guidelines. Strong veterinary administration ensure the use of effective veterinary medicines, including injectable devices for disease control in livestock.
   
• Additionally, Germany is a significant exporter of poultry products within the Europe. In 2023, poultry meat exports from Germany exceeded 380,00 metric tons. Compliance with international veterinary standard, including mandatory vaccination, supports market growth. In addition, zoonotic disease prevention efforts implemented at the regulatory and public health level support widespread adoption of injectable tools in both companion animals and livestock.
   

Asia Pacific Veterinary Injectable Devices Market
 

The Asia Pacific veterinary injectable devices is anticipated to grow at the highest CAGR of 5.4% during the analysis timeframe.
 

• Asia Pacific accounts for more than 50% of the global livestock production, led by China, India and Southeast Asia. The growing demand for meat, milk and poultry is driving large-scale vaccination and therapeutic use in cattle, swine and poultry. In addition, with FAO projecting ~20% increase in protein consumption by 2030 in Asia, efficient injectable devices are critical to sustain productivity, control disease outbreaks and meet food security goals, thereby contributing to market growth.
   
• Moreover, the Asia Pacific region is a hotspot for avian influenza and Newcastle disease outbreaks. India and Indonesia reported multiple cases of H5N1, triggering mass vaccination campaigns. Thus, such disease outbreaks elevate vaccine demand for preventive and emergency use, spurring market growth.
   

China veterinary injectable devices is estimated to grow with a significant CAGR, in the Asia Pacific veterinary injectable devices.
 

• China’s government has tightened food safety and animal health regulations post ASF and avian flu outbreaks. Policies now mandate vaccination compliance, stricter biosecurity and modern veterinary practices, creating steady demand for injection devices across farms, increasing the overall demand for injectable devices thereby driving market growth.
   
• The integration of IoT-based poultry monitoring and automated vaccine delivery system are being adopted in large farms in China. This boosts the efficiency and reliability of vaccination programs, encouraging farms to adopt injectable devices more systematically and on a large scale.
   

Latin America Veterinary Injectable Devices Market
 

Brazil leads the Latin American veterinary injectable devices industry, exhibiting remarkable growth during the analysis period.
 

• Brazilian government programs are promoting animal health through vaccination campaigns and disease control strategies. The surveillance programs such as National Poultry Health Programs (PNFA) promoted mandatory vaccination and biosecurity compliance to ensure consistent vaccine demand, that drives the growth of the market.
   
• Moreover, Brazil relies heavily on injectable vaccines such as foot-and-mouth disease and bovine respiratory disease to manage animal health. For instance, in 2023 nearly 200 million doses of FMD vaccine were administered, that raises the demand for veterinary injectable devices, contributing market growth.
   

Middle East and Africa Veterinary Injectable Devices Market
 

Saudi Arabia market to experience substantial growth in the Middle East and Africa market in 2024.
 

• The government vision 2030 is profiling expansion of veterinary clinics, mobile health units and diagnostic labs. In addition, campaigns for animal welfare disease surveillance and facility inspections highlight strong policy support for veterinary injectable devices, thereby contributing to market growth.
   
• Rising disposable income and shifting lifestyles have spurred a growing interest in companion animals. This feeds demand for routine injectable therapies from preventive vaccinations to chronic disease treatments.
   
• Lastly, Saudi Arabia is fostering local production of veterinary pharmaceuticals, improving both availability and affordability. Moreover, digital platforms including telemedicine and e-pharmacies are enhancing access to injectable treatments, particularly in underserved regions.
   

Veterinary Injectable Devices Market Share

The veterinary injectable devices industry is shaped by a mix of established global leaders and emerging innovators, creating a dynamic and moderately consolidated competitive landscape. Key players such as Merck & Co., Inc., Zoetis, Henke-Sass, Wolf, Neogen Corporation, and NuGen Medical Devices collectively account for a significant portion of the market share, estimated at around 45%. These companies maintain their dominance through strategic investments in research and development, geographic expansion, and regulatory compliance, while also tailoring solutions to meet the evolving needs of injectable devices, particularly in livestock and companion care.
 

To strengthen their market positions, leading firms are adopting multi-pronged strategies including acquisitions, partnerships, and competitive pricing. These efforts aim to make veterinary devices more accessible and cost-effective, while also addressing unmet clinical needs.
 

In addition to these dominant players, companies like Hamilton Company, Allflex USA, Inc., Kruuse, and NuGen Medical Devices Inc. are contributing to the market’s growth through technological innovation, precision delivery systems, and region-specific strategies. Their presence is particularly notable in Asia-Pacific and Latin America, where rising demand for veterinary care and expanding livestock industries are driving increased adoption of injectable solutions.
 

Overall, the market is witnessing intensified competition and greater diversity, as both established and emerging players continue to evolve their offerings and strategies to meet the global demand for effective and efficient veterinary injectable devices.
 

Veterinary Injectable Devices Market Companies

Prominent players operating in the veterinary injectable devices are as mentioned below:
 

• Allflex USA
• Baxter International
• B. Braun Melsungen
• Hamilton Company
• Henke-Sass, Wolf
• Merck & Co.
• Medtronic plc
• Micrel Medical Devices
• Neogen Corporation
• NuGen Medical Devices
• Serumwerk Bernburg
• Terumo Medical Corporation
• Zoetis
  
   
• Zoetis

Zoetis leads the veterinary injectable devices market with a robust portfolio of vaccines and biologics. Its strength lies in global reach, innovation in long acting injectables, and tailored solutions for both companion animals and livestock. The company emphasizes sustained-release technologies and eco-friendly packaging, driving efficiency and compliance in veterinary care.
 

• Baxter International

Baxter International stands out for its expertise in sterile intravenous solutions and parenteral nutrition therapies. While primarily focused on human healthcare, its precision-formulated fluids and infusion systems are increasingly adapted for veterinary use, especially in critical care and surgical settings. Baxter’s global manufacturing footprint and reliability in fluid therapy make it a trusted name in veterinary IV support.
 

• Henke-sass, Wolf

Henke-Sass, Wolf specializes in high-precision, automatic self-filling syringes and multi-dosing injectors for livestock and companion animals. Their modular designs, safety features, and species-specific dosing systems ensure efficient, stress-free administration. With over a century of expertise, HSW’s veterinary injectors are indispensable tools in modern animal healthcare, known for durability and ergonomic innovation.
 

Veterinary Injectable Devices Industry News

• In May 2025, AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced it has signed a binding evaluation and option agreement with Merck Animal Health to develop long-acting formulations, for use in animal health. AmacaThera's unique hydrogel platform technology, AmacaGel, products developed by AmacaThera are designed to enhance the sustained delivery of therapeutic agents with a single injection, potentially revolutionizing animal care and welfare in veterinary medicine.
   
• In June 2022, NuGen Medical Devices, a leader in needle-free drug delivery announced the launch of needle-free injection device specifically designed for domesticated household pets. The PetJet allow pet owners and veterinarians to safely and quickly inject various types of medication without the fear of hurting their pets with a traditional hypodermic needle.
   

The veterinary injectable devices market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Syringes       
• Needles        
• Remote injectable devices  
  • Pole syringes
  • Darts
• Needle free injector systems        
  • Spring-loaded
  • Battery-powered
  • Gas powered jet injector
• Auto-injectors         
• Other injectable devices       

Market, By Material

• Plastic
• Metal
• Glass
• Other materials

Market, By Clinical Applications

• Vaccination and preventive care
• Anti-infectives
• Anesthesia and analgesia
• Fertility and reproduction
• Other clinical applications

Market, By Usage

• Disposable devices
• Reusable devices

Market, By Animal Type

• Companion animals
• Livestock animals
• Other animals

Market, By End Use

• Veterinary hospitals
• Veterinary clinics
• Academic and research institutes
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE